MX2012000957A - Plasma-adapted and balanced gelatin solution. - Google Patents

Plasma-adapted and balanced gelatin solution.

Info

Publication number
MX2012000957A
MX2012000957A MX2012000957A MX2012000957A MX2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A
Authority
MX
Mexico
Prior art keywords
balanced
plasma
gelatin solution
pharmaceutical preparation
gelatin
Prior art date
Application number
MX2012000957A
Other languages
Spanish (es)
Inventor
Michael Boll
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of MX2012000957A publication Critical patent/MX2012000957A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a pharmaceutical preparation which comprises an aqueous composition which in turn comprises gelatin and/or a physiologically acceptable gelatin derivative. The pharmaceutical preparation can be used in the prophylaxis and therapy of hypovolemia. The invention further relates to uses of the pharmaceutical preparation as a volume substitute and as an erythrocyte-protecting wash solution.
MX2012000957A 2009-07-20 2010-07-15 Plasma-adapted and balanced gelatin solution. MX2012000957A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009034132A DE102009034132A1 (en) 2009-07-20 2009-07-20 Plasma adapted and balanced gelatin solution
PCT/EP2010/060210 WO2011009797A2 (en) 2009-07-20 2010-07-15 Plasma-adapted and balanced gelatin solution

Publications (1)

Publication Number Publication Date
MX2012000957A true MX2012000957A (en) 2012-03-06

Family

ID=43334706

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000957A MX2012000957A (en) 2009-07-20 2010-07-15 Plasma-adapted and balanced gelatin solution.

Country Status (9)

Country Link
EP (1) EP2456446A2 (en)
KR (1) KR20120046160A (en)
CN (1) CN102470147A (en)
BR (1) BR112012001229A2 (en)
DE (2) DE102009034132A1 (en)
IN (1) IN2012DN00419A (en)
MX (1) MX2012000957A (en)
RU (1) RU2012105925A (en)
WO (1) WO2011009797A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651717B1 (en) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Isotonic crystalloid aqueous solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
EP0223906A3 (en) * 1982-10-29 1989-02-01 Synthetic Blood Corporation Gelatin based synthetic whole blood and a process for preparing the same
EP1238675A1 (en) 2001-03-06 2002-09-11 Fuji Photo Film B.V. Recombinant gelatin-like proteins for use as plasma expanders

Also Published As

Publication number Publication date
DE202010018349U1 (en) 2015-10-28
EP2456446A2 (en) 2012-05-30
KR20120046160A (en) 2012-05-09
CN102470147A (en) 2012-05-23
WO2011009797A2 (en) 2011-01-27
DE102009034132A1 (en) 2011-01-27
RU2012105925A (en) 2013-08-27
BR112012001229A2 (en) 2016-03-01
WO2011009797A3 (en) 2011-08-25
IN2012DN00419A (en) 2015-05-15

Similar Documents

Publication Publication Date Title
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
SV2011004019A (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONS AND ITS USE
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
CR20130001A (en) DERIVATIVES OF INDOLIZINE, ITS PREPARATION PROCEDURE AND ITS APPLICATION IN THERAPEUTICS
IN2012DN02805A (en)
IN2012DN03312A (en)
MX2011008171A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof.
WO2011009759A3 (en) Use of dihydroquercetin and at least one amino acid to positively influence the natural pigmentation process
MX348823B (en) Stable formulations of linaclotide.
HN2010002518A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A STRONTIUM SALT, VITAMIN D AND A CYCLODEXTRINE
MX342947B (en) Treatment of type 2 diabetes.
DOP2011000245A (en) DERIVATIVES OF TIADIAZOLES AND OXADIAZOLS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
WO2012049307A3 (en) Novel n-terminally modified insulin derivatives
MX2013002948A (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
WO2011106417A3 (en) Garcinia mangostana l. and iridoid based formulations
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
MX2012000954A (en) Pharmaceutical compositions.
MX2012010127A (en) Derivatives of aminoindanes, their preparation and their application in therapeutics.
CR20110701A (en) DERIVADOS DE PIRAZOLES, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION.
CO6290689A2 (en) DERIVATIVES OF 1,2,3,4-TETRAHYDROPIRROLO [1,2] PIRAZINA-6-CARBOXAMIDS AND 2,3,4,5-TETRAHYDROPIRROL [1,2] [1,4] -DIAZEPINA -7-CARBOXAMIDS THEIR PREPARATION AND ITS APPLICATION IN THERAPEUTICS
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
MX2012000957A (en) Plasma-adapted and balanced gelatin solution.
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL

Legal Events

Date Code Title Description
FA Abandonment or withdrawal